Dr. Tsimberidou on the Personalized Medicine Results

Lead author Apostolia M. Tsimberidou, MD, PhD, of the University of Texas MD Anderson Cancer Center, believes that personalized medicine is the future of cancer care and focused on it in a phase I clinical trial conducted at MD Anderson Cancer Center.

The study examined cancer molecular analysis and used matched targeted therapy unique to the aberrations found in the analysis as a way to improve the outcomes of patients. The trial demonstrated that looking at particular genetic abnormalities to select treatment is associated with improved outcomes overall.